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Abstract
Mercury increases the risk of cardiovascular disease and oxidative stress and alters vascular reactivity. This metal elicits
endothelial dysfunction causing decreased NO bioavailability via increased oxidative stress and contractile prostanoid
production. NADPH oxidase is the major source of reactive oxygen species (ROS) in the vasculature. Our aim was to
investigate whether treatment with apocynin, an NADPH oxidase inhibitor, prevents the vascular effects caused by chronic
intoxication with low concentrations of mercury. Three-month-old male Wistar rats were treated for 30 days with a)
intramuscular injections (i.m.) of saline; b) HgCl2 (i.m. 1
st dose: 4.6 mg/kg, subsequent doses: 0.07 mg/kg/day); c) Apocynin
(1.5 mM in drinking water plus saline i.m.); and d) Apocynin plus HgCl2. The mercury treatment resulted in 1) an increased
aortic vasoconstrictor response to phenylephrine and reduced endothelium-dependent responses to acetylcholine; 2) the
increased involvement of ROS and vasoconstrictor prostanoids in response to phenylephrine, whereas the endothelial NO
modulation of such responses was reduced; and 3) the reduced activity of aortic superoxide dismutase (SOD) and
glutathione peroxidase (GPx) and increased plasma malondialdehyde (MDA) levels. Treatment with apocynin partially
prevented the increased phenylephrine responses and reduced the endothelial dysfunction elicited by mercury treatment.
In addition, apocynin treatment increased the NO modulation of vasoconstrictor responses and aortic SOD activity and
reduced plasma MDA levels without affecting the increased participation of vasoconstrictor prostanoids observed in aortic
segments from mercury-treated rats. Conclusions: Mercury increases the vasoconstrictor response to phenylephrine by
reducing NO bioavailability and increasing the involvement of ROS and constrictor prostanoids. Apocynin protects the
vessel from the deleterious effects caused by NADPH oxidase, but not from those caused by prostanoids, thus
demonstrating a two-way action.
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Introduction
Mercury is a heavy metal that affects the activity of several
enzymes, ion channels and receptors [1] by binding to the SH
groups [2] that are necessary for normal enzyme function. This
metal is a public health problem because many populations
worldwide are exposed to mercury at levels that exceed the
recommended safety guidelines [3]. Despite attempts to control
industrial pollution, mercury poisoning still occurs from exposure
to methylmercury (MeHg) from fish, ethylmercury from vaccine
products, metallic mercury from dental amalgam fillings, cinnabar
from Chinese herbal balls, and other sources of domestic mercury
contamination [4,5].
The harmful effects of mercury during its accumulation in
humans are mostly due to the excessive release of reactive oxygen
species (ROS), the increased lipid peroxidation in the cells and the
reduction of antioxidant defenses, thus inactivating important
enzymes that are responsible for body’s defenses, such as
glutathione reductase (GR), glutathione peroxidase (GPx), super-
oxide dismutase (SOD), catalase (CAT) and GSH in different
organs [6,7]. These effects are capable of damaging the integrity
and altering the function of membranes, which can lead to the
development of many pathological processes [8]. Because mercury
exposure is associated with oxidative stress and endothelial
dysfunction, more attention has been paid to its toxic effects on
the cardiovascular system and its association with hypertension,
carotid atherosclerosis, myocardial infarction, and coronary heart
disease [9,10].
Previous studies from our group have demonstrated that
oxidative stress caused by mercury exposure decreases the
bioavailability of nitric oxide (NO) and alters the expression of
NO synthase (NOS), leading to increased vasoconstriction, the
reduction of endothelial vasodilator response and the stimulation
of cyclooxygenase (COX)-derived vasoconstrictor prostanoids
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release [11–14]. NADPH oxidase, a multisubunit enzymatic
complex, has been considered the major source of ROS in
vascular cells [15] and has been suggested to be responsible for the
endothelial dysfunction observed in different cardiovascular
pathologies [10,16]. Interestingly, previous studies have also
reported that the activation of NADPH oxidase may be associated
with exposure to mercury in mesenteric and coronary arteries
[12,14].
Therefore, the aim of this study was to assess whether treatment
with the NADPH oxidase inhibitor apocynin can prevent or
mitigate the changes caused by chronic exposure to low doses of
mercury on a) the endothelial modulation of vasoconstrictor and
vasodilator responses in conductance arteries; b) ROS and COX
participation in these vascular responses; and c) ROS production
and antioxidant activity.
Materials and Methods
Animals
Three-month-old male Wistar rats (290–310 g) were obtained
from the Central Animal Laboratory of the Federal University of
Santa Maria, Rio Grande do Sul, Brazil. During treatment, rats
were housed at a constant room temperature, humidity, and light
cycle (12:12 h light-dark), free access to tap water and fed with
standard chow ad libitum. All experiments were conducted in
compliance with the guidelines for biomedical research stated by
the Brazilian Societies of Experimental Biology and approved by
the Ethics Committee on Animal Experimentation of the Escola
de Ensino Superior da Santa Casa de Miserico´rdia de Vito´ria,
EMESCAM, Vito´ria, Espı´rito Santo, Brazil (Process Number:
010/2011).
Rats were divided into four groups and treated for 30 days as
follows: a) Untreated (saline solution, i.m.); b) Mercury (HgCl2) -
mercury chloride (1st dose 4.6 mg/kg, subsequent doses 0.07 mg/
kg/day, i.m., to cover daily loss, using the model described by
Wiggers et al. [17]); c) Apocynin (Apo) - apocynin (1.5 mM in
drinking water plus saline solution, i.m.); and d) Apocynin-mercury
(ApoHg) - mercury chloride plus apocynin.
Systolic (SBP) and diastolic (DBP) blood pressure
Rats were anesthetized with urethane (1.2 g/kg, i.p.), and after
loss of the righting reflex, the carotid artery was cannulated with a
polyethylene catheter (PE 10, Clay-Adams, NY, USA), filled with
saline plus heparin (50 U/ml) to measure arterial pressure. SBP
and DBP were measured using a pressure transducer (TSD104A)
connected to an amplifier and an acquisition system (MP 150
Biopac Systems, Inc., CA, USA) and were continuously moni-
tored. After a 30-min stabilization period, the SBP and DBP were
obtained and recorded.
Blood collection and reactivity experiments
Rats were submitted to a surgical procedure to expose and
puncture the renal artery; blood was subsequently collected to
obtain plasma for the biochemical experiments. Thereafter, rats
were euthanized by decapitation, and the thoracic aorta was
carefully dissected out and cleaned of connective tissue. For
reactivity experiments, the thoracic aorta was divided into
segments that were 2 mm in length. For isometric tension
recording, each aortic segment was set up in an organ bath
containing 5 ml of Krebs-Henseleit solution (KHS, in mM: 115
NaCl, 25 NaHCO3, 4.7 KCl, 1.2 MgSO4 7H2O, 2.5 CaCl2, 1.2
KH2PO4, 11.1 glucose and 0.01 Na2EDTA) at 37uC and
continuously gassed with a 95%O2-5%CO2 mixture (pH = 7.4).
Two horizontally arranged stainless steel pins (75 mm in diameter)
were passed through the lumen: one was fixed to the organ bath
wall, and the other was vertically connected to a force-
displacement transducer (TSD125BX8 - Biopac Systems, Inc)
and a recorder (MP150WSW-SYS - Biopac Systems, Inc).
Aortic segments were subjected to a tension of 1.5 g that was
readjusted every 15 min during a 60-min equilibration period
before drug administration. Vessels were initially exposed to
75 mM KCl to check their functional integrity, and the presence
of endothelium was confirmed by the ability of acetylcholine
(10 mM) to relax segments contracted with phenylephrine at a
concentration that produces close to 50% of the contraction
induced by 75 mM KCl. After 60 min of washout, a single
concentration-response curve to phenylephrine (0.01 nM –
300 mM) was performed.
To evaluate the role of the endothelium in the vasoconstrictor
response to phenylephrine, some rings had their endothelium
removed mechanically, and its absence was confirmed by the
inability of acetylcholine to induce relaxation greater than 10% of
the previous contraction to phenylephrine. The effects of Nv-
Nitro-L-arginine methyl ester hydrochloride (L-NAME –
100 mM), indomethacin (1 mM) and apocynin (0.3 mM) were
investigated by their addition 30 min before phenylephrine in
vessels with intact endothelium. Thus, to evaluate the participation
of NO, prostanoids or ROS on phenylephrine responses, the effect
of the in vitro addition of those drugs was compared with the
control situation (intact endothelium) in the absence or drugs.
To evaluate the relaxation dependent and independent of the
endothelium, concentration-response curves were performed with
acetylcholine (0.01 nM – 300 mM) and sodium nitroprusside
(SNP, 0.01 nM – 300 mM), respectively.
Lipid peroxidation in plasma
Plasma thiobarbituric acid-reacting substances (TBARS) are
lipid peroxidation products that are considered an expression of
systemic oxidative stress and are measured as malondialdehyde
(MDA) using a colorimetric method, as previously described by
Ohkawa et al. [18], with modifications. Blood was collected by
renal puncture and transferred into tubes containing the
anticoagulant EDTA (Wiener Lab, Rosario, Argentina). Plasma
was obtained by centrifugation (1500xg, 4uC, 15 min). An aliquot
of plasma was incubated with thiobarbituric acid 0.8% (TBA),
phosphoric acid buffer 1% (H3PO4), and sodium dodecil sulphate
0.8% (SDS) at 100uC for 60 min. The color reaction was
measured at 532 nm against blanks (Spectrophotometer Femto
600 S, FEMTO, Sa˜o Paulo, Brazil). The results were expressed as
nanomoles of MDA per ml of plasma.
Thiol groups in plasma
The total concentration of thiol groups (SH) was measured
using spectrophotometry at 412 nm, according to Ellman’s
method [19]. An aliquot of blood plasma was mixed with 10%
SDS and 1 M phosphate buffer (pH 8), and the absorbance was
measured at 412 nm (A0) against blank. Then, 5,5’-dithio-bis-2-
nitrobenzoic acid 10 mM (DTNB) was added followed by
incubation at 37uC for 60 min. After incubation, the absorbance
of the sample was again measured at 412 nm (A1). The result is
the difference between A1-A0 and was expressed as nanomoles of
thiol groups per ml of plasma.
Superoxide dismutase (SOD) and glutathione peroxidase
(GPx) activity in aortas
SOD activity in aorta homogenate was assayed using spectro-
photometry, as described by Misra and Fridovich [20]. This
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method is based on the capacity of SOD to inhibit the
autoxidation of adrenaline to adrenochrome. The color reaction
was measured at 480 nm. One unit of enzyme was defined as the
amount of enzyme required to inhibit the rate of epinephrine
autoxidation by 50% at 26uC. Aortas were washed with ice-cold
saline and rapidly homogenized in 50 mM Tris–HCl, pH 7.5
(1:10, w/v) and centrifuged at 2400xg for 15 min at 4uC. The
supernatants (S1) were then separated. The S1 was diluted 1:10
(v/v) for determination of SOD activity on test day and added to a
50 mM glycine buffer (pH 10.3). The enzymatic reaction was
started by adding 60 mM epinephrine, and the enzymatic activity
was expressed as Units (U) per mg of protein.
GPx activity in aorta tissue was assayed using spectrophotom-
etry using the method of Wendel [21] through the reduced
glutathione (GSH)/b tetrasodium salt (NADPH)/glutathione
reductase system by the dismutation of H2O2 at 340 nm. In this
assay, the enzyme activity was indirectly measured using an
NADPH decay. H2O2 was decomposed, generating oxidized
glutathione (GSSG) from GSH. GSSG was regenerated back to
GSH by glutathione reductase present in the assay medium at the
expense of NADPH. S1 was added to the GSH/NADPH/
glutathione reductase system, and the enzymatic reaction was
initiated by adding H2O2 4 mM. The enzymatic activity was
expressed as nmol NADPH/per min per mg protein. Proteins for
both experiments were measured according to Bradford using
bovine serum albumin as a standard.
Drugs and reagents
HgCl2, apocynin, phenylephrine hydrochloride, acetylcholine
chloride, SNP, urethane, L-NAME and indomethacin were
purchased from Sigma-Aldrich (St Louis, MO, USA); heparin
was purchased from Roche (Sa˜o Paulo, SP, Brazil). Salts and
reagents, when not specified, were of analytical grade obtained
from Sigma and Merk (Darmstadt, Germany).
Data analysis and statistics
All values are expressed as the mean6SEM of the number of
animals used in each experiment. In the vascular reactivity
experiments, vasoconstrictor responses were expressed as the% of
contraction induced by 75 mM KCl and vasodilator responses as
the% of the previous contraction to phenylephrine. To compare
the effect of L-NAME, apocynin and indomethacin on the
Figure 1. Effect of apocynin treatment on systolic and diastolic blood pressure. Values of (A) systolic (SBP) and (B) diastolic blood pressure
(DBP, mmHg) in the aorta of rats untreated (n = 9) or treated with mercury (HgCl2, n = 8), apocynin (Apo, n = 9) or apocynin plus mercury (ApoHg,
n = 9). The results are expressed as the mean6SEM, t-test *P,0.05 vs. Untreated.
doi:10.1371/journal.pone.0055806.g001
Figure 2. Effect of apocynin treatment on the vascular relaxation response to acetylcholine and sodium nitroprusside.
Concentration-response curves to (A) acetylcholine (ACh) and (B) sodium nitroprusside (SNP) in the aortas of rats untreated, treated with mercury
(HgCl2) or apocynin plus mercury (ApoHg) pre-contracted with phenylephrine. The results (mean6SEM) are expressed as a percentage of the
response to phenylephrine. The number of animals used is indicated in parentheses. Two-Way ANOVA *P,0.05.
doi:10.1371/journal.pone.0055806.g002
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response to phenylephrine in segments from the different groups,
some results were expressed as ‘differences of area under the
concentration-response curves’ (dAUC) in control and experimen-
tal situations. AUCs were calculated from the individual concen-
tration-response curve plots; the differences were expressed as the
percentage of the AUC of the corresponding control situation.
The results were analyzed using either Student’s t-test or two-way
ANOVA for comparison between groups. When ANOVA showed
a significant treatment effect, Bonferronis post hoc test was used to
compare individual means. Differences were considered statisti-
cally significant at P,0.05.
Results
No differences in body weight were observed between all groups
before and after treatment with mercury, as previously described
[17]. (Untreated: 302.4 6 30.1 g before and 332.7 6 26.3 g after;
HgCl2-treated: 309.66 56.8 g before and 346.36 54.2 g after - t-
test - P.0.05). Apocynin alone or co-treatment with mercury plus
apocynin did not change this parameter (ApoHg-treated: 309.0 6
28.4 g before and 347.4 6 26.1 g after; Apo-treated: 299.3 6
46.4 g before and 335.4 6 36.1 g after - t-test - P.0.05).
Effect of apocynin on systolic and diastolic blood
pressure
Chronic treatment with low doses of mercury did not change
either SBP or DBP. Apocynin decreased SBP and DBP in
untreated rats; however, it was unable to exert this effect in the
group treated concomitantly with mercury (Figure 1).
Apocynin treatment improves endothelium-dependent
vasodilator responses and reduces vasoconstrictor
responses in mercury-treated rats
Exposure to acetylcholine and SNP produced concentration-
dependent relaxation in the aortic rings from all groups. As
previously described [12], chronic exposure to mercury reduced
the vascular response to acetylcholine and co-treatment with
apocynin prevented this reduction (Figure 2A, Table 1). SNP
responses were similar in untreated, mercury-treated and mercury-
treated plus apocynin (Figure 2B, Table 1). Apocynin treatment
did not affect the acetylcholine or SNP responses in the absence of
mercury (Table 1). These results suggest that chronic exposure to
Table 1. Effects of apocynin treatment of rats in the absence
and in the presence of HgCl2 on maximum response (Rmax)
and sensitivity (pD2) to acetylcholine and sodium
nitroprusside.
ACh SNP
Rmax pD2 Rmax pD2
Untreated 102.2613.7 -8.161.4 100.261.6 29.560.5
HgCl2 78.369.3* 27.161.3 99.763.4 29.060.6
Apo 97.169.1 27.961.8 95.967.3 28.360.3
ApoHg 96.468.3# 28.461.2 100.462.6 29.160.4
Parameters of maximal response (Rmax) and sensitivity (pD2) of the
concentration-response curves to acetylcholine (ACh) and sodium nitroprusside
(SNP) in aortas from rats untreated, treated with mercury (HgCl2), apocynin and
apocynin plus mercury (ApoHg) in intact segments (Control). Results are
expressed as mean6SEM. Rmax, maximal effect (expressed as a percentage of
the previous contraction to phenylephrine) and pD2 expressed as -log one-half
Rmax; t-test: *P,0.05 vs. Untreated;
#P,0.05 vs. HgCl2-treated.
doi:10.1371/journal.pone.0055806.t001
Figure 3. Effect of apocynin treatment on the vasoconstrictor
response to phenylephrine. Concentration-response curve to
phenylephrine (Phe) in the aortas of rats untreated, treated with
mercury (HgCl2), and apocynin plus mercury (ApoHg). The results
(mean6SEM) are expressed as a percentage of the response to
75 mmol/l KCl. The number of animals is indicated in parentheses. Two-
Way ANOVA *P,0.05.
doi:10.1371/journal.pone.0055806.g003
Table 2. Effects of apocynin treatment of rats in the absence and in the presence of HgCl2 on maximum response (Rmax) and
sensitivity (pD2) to phenylephrine.
Untreated HgCl2 Apo ApoHg
Rmax pD2 Rmax pD2 Rmax pD2 Rmax pD2
Control 75.665.4 26.960.2 98.366.8# 27.060.2 90.365.7 28.561.4 84.764.9 26.960.2
E- 135.565.9* 214.861.9* 142.966.3* 213.461.6* 139.964.9* 214.262.5* 152.567.1* 216.361.8*
L-NAME 159.366.7* 210.361.4* 145.765.0* 210.361.3* 155.768.1* 211.861.6* 153.668.3* 29.761.1*
Apocynin 31.864.6* 26.660.1 25.864.7* 26.560.2 37.065.7* 26.660.2 40.966.4* 26.760.2
Indomethacin 46.565.6* 26.860.1 35.665.6* 26.760.1 51.865.3* 26.960.1 30.961.9*# 26.760.2
Parameters of maximal response (Rmax) and sensitivity (pD2) of the concentration-response curves to phenylephrine in aortas from rats untreated, treated with mercury
(HgCl2), apocynin and apocynin plus mercury (ApoHg) in intact (Control) and endothelium removal (E-) segments and in the presence of L-NAME (100 mM), Apocynin
(0.3 mM) or Indomethacin (1 mM) incubation. Results are expressed as mean6SEM. Rmax, maximal effect (expressed as a percentage of maximal response induced by
75 mM KCl) and pD2 expressed as -log one-half Rmax; t-test: *P,0.05 compared to the corresponding control in each group;
#P,0.05 vs. Untreated group.
doi:10.1371/journal.pone.0055806.t002
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low doses of mercury promoted endothelial dysfunction in the rat
aorta, which was prevented by apocynin.
Vasoconstrictor responses to 75 mM KCl were similar (P.0.05)
in aortas from mercury (1.5260.24 g; n = 17), apocynin
(1.4860.27 g; n = 18), and apocynin-mercury (1.4660.17 g;
n = 16) groups compared to the untreated group (1.5360.24 g;
n = 19). In apocynin-treated rats, the response to phenylephrine
was similar to that of untreated rats (Table 2). Treatment with
mercury for 30 days increased the vasoconstrictor responses
induced by phenylephrine in endothelium-intact aortic rings, as
previously described [13,17]. Co-treatment with apocynin partially
prevented the increase in contractile response to phenylephrine in
these arteries (Figure 3); thus, while mercury treatment increased
the maximum response (Rmax), this increase was not observed in
rats co-treated with apocynin (Table 2).
Apocynin treatment diminishes the deleterious effect of
mercury on endothelial NO modulation of
vasoconstrictor responses
Mechanical removal of the endothelium caused a significant
increase in the phenylephrine response in all groups (Figure 4,
Figure 4. Effect of apocynin treatment on endothelial modulation of the vasoconstrictor response to phenylephrine. Concentration-
response curve to phenylephrine (Phe) in intact (Control) and endothelium removal (E-) aortic segments of rats (A) untreated, (B) treated with
apocynin (Apo), (C) mercury (HgCl2), and (D) apocynin plus mercury (ApoHg). The results (mean6SEM) are expressed as a percentage of the response
to 75 mmol/l KCl. The number of animals is indicated in parentheses. *P,0.001 by Two-Way ANOVA. (E) Differences in the area under the
concentration-response curves (dAUC) in endothelium denuded and intact segments of the four experimental groups. * P,0.05 vs. Untreated and #
vs. HgCl2-treated by t-test.
doi:10.1371/journal.pone.0055806.g004
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Table 2). The effect of endothelium removal was smaller in
mercury-treated animals, as shown by the dAUC values,
indicating that mercury treatment reduced the negative modula-
tion induced by the endothelium of the contractile response to
phenylephrine. In apocynin-treated rats, the effect of endothelium
removal was similar to untreated rats, while the co-treatment of
mercury with apocynin (Figure 4E) prevented the reduction of
endothelial modulation.
To verify that the reduction of endothelial modulation in the
vascular response to phenylephrine was due to alterations in the
effects of NO, we used the NOS inhibitor L-NAME (100 mM) in
vitro. This drug promoted an increase in the response to
phenylephrine in arteries from both untreated and mercury-
treated rats (Figure 5, Table 2). However, the dAUC values show
that this increase was smaller in rats treated with mercury when
compared to untreated (Figure 5E). Co-treatment with apocynin
restored the potentiating effect of L-NAME in mercury-treated
rats (Figure 5). In the group treated only with apocynin, L-NAME
promoted increased sensitivity and maximal response to phenyl-
ephrine similar to that observed in the untreated group (Table 2).
All of these results suggest that chronic treatment with low doses of
mercury reduced NO bioavailability and its modulation of the
Figure 5. Effect of apocynin treatment on NO modulation of the vasoconstrictor response to phenylephrine. Concentration-response
curve to phenylephrine (Phe) in aortic segments of rats (A) untreated, (B) treated with apocynin (Apo), (C) mercury (HgCl2), and (D) apocynin plus
mercury (ApoHg) in the absence (Control) and the presence of the NO synthase inhibitor L-NAME (100 mM). The results (mean6SEM) are expressed as
a percentage of the response to 75 mmol/l KCl. The number of rats is indicated in parentheses. *P,0.001 by Two-Way ANOVA. (E) Differences in the
area under the concentration-response curve to phenylephrine (dAUC) in aortic segments in the presence and the absence of L-NAME of the four
experimental groups. * P,0.05 vs. Untreated and # vs. HgCl2-treated by t-test.
doi:10.1371/journal.pone.0055806.g005
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contractile response to phenylephrine in rat aortas by the increase
in superoxide anion production.
Apocynin reduces the increased participation of ROS in
vasoconstrictor responses of mercury-treated rats
To further evaluate the contribution of oxidative stress in the
vascular alterations induced by mercury, we assessed the role of
superoxide anion in phenylephrine responses using apocynin
(0.3 mM) in vitro. This drug decreased the phenylephrine responses
in arteries from both untreated and mercury-treated rats (Figure 6,
Table 2). However, this inhibitory effect was higher in rats treated
with mercury compared to the effect observed in untreated rats
(Figure 6E). Co-treatment with apocynin restored the inhibitory
effect of apocynin (in vitro) in mercury-treated rats. In vitro apocynin
incubation in rats treated with apocynin induced a decrease in the
response to phenylephrine similar to that observed in untreated
rats.
Figure 6. Effect of apocynin treatment on ROS modulation of the vasoconstrictor response to phenylephrine. Concentration-response
curve to phenylephrine (Phe) in aortic segments of rats (A) untreated, (B) treated with apocynin (Apo), (C) mercury (HgCl2), and (D) apocynin plus
mercury (ApoHg) in the absence (Control) and the presence of the NADPH oxidase inhibitor Apocynin (0.3 mM). The results (mean6SEM) are
expressed as a percentage of the response to 75 mmol/l KCl. The number of rats is indicated in parentheses. *P,0.001 by Two-Way ANOVA. (E)
Differences in the area under the concentration-response curve to phenylephrine (dAUC) in aortic segments incubated in the absence and the
presence of apocynin of the four experimental groups. * P,0.05 vs. Untreated and # vs. HgCl2-treated by t-test.
doi:10.1371/journal.pone.0055806.g006
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Effect of apocynin on lipid peroxidation and thiol groups
in plasma
Chronic treatment with low doses of mercury promoted an
increase in oxidative stress and lipid peroxidation, as demonstrated
by increased plasma MDA levels. Apocynin co-treatment
prevented the increase in plasma MDA levels (Figure 7A),
suggesting that the superoxide anion produced by exposure to
mercury might be the main ROS involved in this oxidative stress.
Mercury treatment also increased the plasma levels in SH
groups (Figure 7B). Co-treatment with apocynin did not alter the
increase of thiol groups resulting from exposure to the metal. In
addition, SH groups were increased in the apocynin group
(Figure 7B).
Effect of apocynin on superoxide dismutase (SOD) and
glutathione peroxidase (GPx) activity
Chronic exposure to low doses of mercury caused a reduction in
aortic SOD activity (Figure 8A). Apocynin not only prevented this
reduction, but it also increased the enzyme activity when
compared to untreated animals both in the absence and presence
of mercury (Figure 8A). In rats exposed to mercury for 30 days, a
reduction in aortic GPx activity was also observed (Figure 8B).
Apocynin failed to prevent this reduction caused by the metal
(Figure 8B). This result suggests that apocynin does not act on the
GPx pathway.
Apocynin treatment does not modify the participation of
prostanoids on vasoconstrictor responses in mercury-
treated rats
Previous studies have shown that the increased participation of
COX vasoconstrictor prostanoids may be associated with oxida-
tive stress, hypertension and increased vascular reactivity [22,23].
We found that the COX inhibitor indomethacin (1 mM) reduced
the response to phenylephrine more in arterial segments of
mercury-treated than untreated rats (Figure 9, Table 2), as
previously described [13]. Apocynin co-treatment of mercury-
treated rats did not modify the effect of indomethacin on
phenylephrine responses. These results suggest that in rats treated
with mercury, there is greater participation of vasoconstrictor
prostanoids derived from COX on the vasoconstrictor response to
phenylephrine, which was not dependent on the observed
increased oxidative stress.
Discussion
The present study shows, for the first time, that apocynin
treatment normalizes endothelial dysfunction in the aortas of rats
chronically exposed to low doses of mercury chloride. This effect is
likely due to its action on NADPH oxidase, preventing mercury-
induced oxidative stress, as demonstrated by decreased plasma
MDA and the increased activity of SOD, resulting in increased
NO bioavailability in the aortic tissue. Our results also show that
mercury increases phenylephrine responses by acting on oxidative
stress and COX pathways. A blockade of NADPH oxidase
partially prevents the mercury-induced phenylephrine hyperre-
sponsiveness by reducing oxidative stress without affecting COX
pathways.
Mercury has been identified as a hazard and risk factor for
cardiovascular disease in humans [10]. The United States
Environmental Protection Agency recommends a maximum blood
concentration of mercury of 5.8 ng/ml; below this concentration,
mercury exposure is considered to be without adverse effects
[3,24]. Several studies have shown blood mercury level in residents
of contaminated areas and in mercury-exposed workers ranging
from 7 to 10 ng/ml [25]. In the present study, we used a
controlled low-dose administration of mercury chloride and
attained a blood mercury content of approximately 8 ng/ml
[17], close to the human exposure levels.
It has been shown that mercury exposure increases the risk of
hypertension, carotid atherosclerosis and coronary heart disease
[26]. We have recently described that 30 days of exposure to low
doses of HgCl2 produces important vascular dysfunction in the
aorta, coronary and mesenteric resistance arteries [12–14]. These
effects can be explained, at least in part, by the oxidative stress
caused by mercury, which is responsible for increasing the
production of ROS, reduction of NO bioavailability and
endothelial dysfunction. In fact, oxidative stress is well document-
ed in mercury poisoning as demonstrated by increased lipid
peroxidation [27] and decreased antioxidant defenses of the body
[28,29]. The damage caused by this metal on the cardiovascular
system can be attributed to the activation of many ROS sources,
but to our knowledge, this is the first study demonstrating the
essential role of NADPH oxidase in mercury-induced vascular
dysfunction.
The effects caused by mercury exposure on blood pressure vary
with the dose of metal and exposure time. Acute administration of
Figure 7. Effect of apocynin treatment on lipid peroxidation and thiol groups in plasma. Values of (A) TBARS and (B) thiol (SH) groups in
the plasma of rats untreated (n = 7) and treated with mercury (HgCl2, n = 7), apocynin (Apo, n = 6) and apocynin plus mercury (ApoHg, n = 9). Data are
expressed as the mean6SEM, t-test *P,0.05 vs. Untreated and #P,0.05 vs. HgCl2-treated.
doi:10.1371/journal.pone.0055806.g007
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a high concentration of mercury decreases arterial blood pressure
in rats, [30,31] while chronic treatment showed the opposite effect
[9,32]. However, exposure to nanomolar doses of mercury does
not promote changes in blood pressure [11–14]. The results
obtained in this study confirm and extend previous findings [17],
demonstrating that there are no changes in systolic and diastolic
blood pressure by exposure to low doses of mercury. Interestingly,
apocynin reduced systolic and diastolic blood pressures in the
control rats, but it did not do so in the mercury-treated rats. We do
not have a clear explanation of these findings, but possibilities
include higher resistance to apocynin effects in mercury-treated
animals by affecting other organs involved in blood pressure
control such as the kidneys or heart. Future studies on these issues
will clarify this point.
The exposure to mercury impaired vasodilator responses to
acetylcholine, as previously shown [11–13]. Because the vascular
response to sodium nitroprusside was unaffected by mercury, these
findings suggest the presence of endothelial dysfunction secondary
to the metal exposure, independent of smooth muscle sensitivity to
NO. Apocynin administration normalized the impaired acetyl-
choline response in mercury-treated rats, suggesting that vascular
NADPH oxidase plays a role in the endothelial dysfunction of
conductance arteries in rats chronically exposed to low concen-
trations of mercury. The ability of apocynin to improve
endothelial-dependent vasodilator responses has been described
in different hypertension models [23,33,34]. In addition, we have
previously demonstrated that when administered in vitro in the
organ bath, apocynin also improved the impaired response to
acetylcholine in aortas from mercury-treated rats [12].
In our study, we also observed an increase in vascular reactivity
to phenylephrine in aortas of rats exposed to mercury. Similar
findings were reported using either high or low mercury
concentrations in vitro [11,17]. Furthermore, we observed that
endothelium removal abolished this effect, suggesting that mercury
produces changes at the endothelial level. This finding is
reinforced by the mentioned decrease of the endothelium-
dependent vasodilator response induced by acetylcholine. Impor-
tantly, co-treatment with apocynin prevents the above-mentioned
changes, suggesting that mercury acts mainly through the
activation of NADPH oxidase by affecting the endothelial
modulation of phenylephrine responses. More specifically, mer-
cury decreased NO availability, as demonstrated by the effect of L-
NAME on phenylephrine responses being smaller in mercury-
treated animals than in untreated animals and apocynin normal-
izing this effect.
As expected, the apocynin treatment of rats prevented the
increased participation of superoxide anion in the contractile
response to phenylephrine in the aortas of rats chronically exposed
to HgCl2. Previous studies have demonstrated that apocynin
reverses endothelial NO dysfunction in animals or humans with
elevated levels of oxidative stress [35]. Other authors have
reported a protective effect of in vivo treatment with apocynin in
experimental models of vascular injury associated with ROS
overproduction [36–38]. Therefore, apocynin appears to be an
effective NADPH oxidase inhibitor in vivo and acts to prevent
vascular damage associated with oxidative stress increases such as
chronic mercury exposure.
Although apocynin co-treatment affected phenylephrine re-
sponses, only a partial prevention of the mercury-induced effect
was observed, indicating that other endothelial factors are also
involved in the generation of the harmful effects induced by HgCl2
intoxication. Indomethacin, a non-selective COX inhibitor,
reduced the contractile response to phenylephrine in segments
from all groups, but this reduction was greater in the group treated
with mercury, showing that in this group, there was increased
participation of the COX pathway in vascular responses. In
agreement, we previously demonstrated the involvement of COX-
derived vasoconstrictor prostanoids in the vascular effects of high
concentrations of HgCl2 [11] or in the same model as used here
[13]. Some studies have demonstrated the existence of a reciprocal
feed-forward relationship between the NADPH oxidase COX
pathway in hypertension [22,34,39]. However, in our experimen-
tal conditions, co-treatment with apocynin did not modify the
increased participation of the COX pathway in the contractile
response to phenylephrine caused by mercury, indicating that
activation of COX seems independent of oxidative stress
generated by NADPH oxidase.
Exposure to HgCl2 increases the levels of thiol (SH) groups as
well as plasma lipid peroxidation, as evidenced by the increased
levels of MDA. It has been described that Hg2+ reacts with SH
groups, thus depleting intracellular thiols, especially glutathione
(GSH), and causing cellular oxidative stress or predisposing cells to
it [40] and forming free radicals that may further increase lipid
peroxidation. However, in our experimental conditions, the
increase in SH groups caused by mercury may be related to the
Figure 8. Effect of apocynin treatment on SOD and GPx activity. Values of (A) SOD and (B) GPx activities in the aortas of rats untreated (n = 6)
and treated with mercury (HgCl2, n = 6), apocynin (Apo, n = 6) and apocynin plus mercury (ApoHg, n= 6). Data are expressed as the mean6SEM. t-test
*P,0.05 vs. Untreated and #P,0.05 vs. HgCl2-treated.
doi:10.1371/journal.pone.0055806.g008
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time and concentration used and may generate a compensatory
mechanism.
The increase in oxidative stress may be due to a decrease in the
antioxidant defenses or to an increase in the production of ROS
[41,42]. Our study showed that exposure to mercury also reduced
SOD and GPx activities. Similarly, Benov et al. [43] showed that
mercury inhibits the activity of several antioxidant enzymes such
as CAT, SOD and GPx in the blood, liver and kidneys of
mercury-poisoned rats. It was also demonstrated that GPx and
SOD activities were significantly lower in erythrocytes from
occupationally-exposed workers [44]. Recently, it was further
demonstrated that chronic exposure to high doses of methylmer-
cury in drinking water reduced the activity of selenoproteins such
as GPx in the cortex and cerebellum of mice, which was attributed
to reduced gene expression of these enzymes [45]. In addition,
Zalups et al. [7] observed that exposure to mercury may also
reduce non-enzymatic antioxidant defenses, such as GSH, the
major low-molecular-mass thiol compound present in virtually all
mammalian tissues [46]. In contrast, in another study with
occupational exposure to mercury in elementary form (Hg),
increases in GSH, glutathione reductase (GR) and CAT activity
were observed in erythrocytes from miners [8], which have been
Figure 9. Effect of apocynin treatment on prostanoid modulation of the vasoconstrictor response to phenylephrine. Concentration-
response curve to phenylephrine (Phe) in aortic segments of rats (A) untreated, (B) treated with apocynin (Apo), (C) mercury (HgCl2), and (D) apocynin
plus mercury (ApoHg) in the absence (Control) and the presence of the non-selective COX inhibitor Indomethacin (1 mM). The results (mean6SEM)
are expressed as a percentage of the response to 75 mmol/l KCl. The number of rats is indicated in parentheses. *P,0.001 by Two-Way ANOVA. (E)
Differences in the area under the concentration-response curve to phenylephrine (dAUC) in aortic segments in the absence and the presence of
indomethacin of the four experimental groups. * P,0.05 vs. Untreated by t-test.
doi:10.1371/journal.pone.0055806.g009
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attributed to compensatory mechanisms due to low levels of
exposure. The co-treatment with apocynin not only prevented the
reduction in SOD activity caused by mercury in aortas but also
promoted an increase in its activity. However, this was not the case
for GPx, suggesting that NADPH oxidase-derived ROS are able to
modulate SOD activity at the vascular level.
In summary, our results demonstrate for the first time that the
NADPH oxidase inhibitor apocynin can partially prevent the
increase in vascular reactivity to phenylephrine and improve the
endothelial dysfunction in aortas of rats chronically exposed to
nanomolar concentrations of mercury. This effect is due to the
prevention of oxidative stress, lipid peroxidation and depletion of
defense mechanisms caused by this metal. In addition, we
demonstrated that mercury acts using two different and indepen-
dent pathways, i.e., NADPH oxidase and COX, whereas only the
NADPH oxidase pathway is affected by apocynin treatment.
These results suggest that the therapeutic use of apocynin in
preventing deleterious effects on the cardiovascular system caused
by occupational exposure to mercury may have important clinical
implications and should continue to be extensively studied.
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